InkVivo is a biomaterial platform that revolutionizes the way drugs are administered.
InkVivo has raised $1.4M in total funding. The most recent round was Pre-Seed. The last funding was announced in August 2025.
InkVivo's investors include TiVentures, Talent Kick, Claves Investments.
InkVivo is headquartered in Zürich, Switzerland.
InkVivo is a biomaterial platform that revolutionizes the way drugs are administered.
InkVivo is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"InkVivo — Funding & Investors." VCBacked, August 13, 2025, https://www.vcbacked.co/company/inkvivo. Accessed September 29, 2026.
VCBacked. (2025). InkVivo — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/inkvivo
{{cite web |title=InkVivo — Funding & Investors |url=https://www.vcbacked.co/company/inkvivo |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated